Episode
Why Cobbles Cost Cyclists / Cheap Carbon Shoes Break Records / Doping Confessions and Cons
- Published
- Apr 8, 2026
- Duration seconds
- 4549
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-real-science-of-sport-podcast-495514/episodes/why-cobbles-cost-cyclists-cheap-carbon-shoes-break-records-doping-confessions-and-cons/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-real-science-of-sport-podcast-495514/why-cobbles-cost-cyclists-cheap-carbon-shoes-break-records-doping-confessions-and-cons.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Become a Science of Sport Supporter by making a small monthly pledge . You'll show your support, help us stay "athletic-greens-free", and get access to our world-class discussion forums In this Spotlight, we start on the cobbled roads of Belgium to explore why riding on cobbles is so hard, and how not so good vibrations compromise mechanical power, cost more energy and require more exertion to produce the same power output. It's Pogacar vs van der Poel, Round 3 this week on the cobbles of Roubaix, and we wonder whether smart tactics will be enough to overcome the Slovenian's firepower, and whether van der Poel's larger size may tilt the balance in his favour? We discuss Jimmy Gressier's return, in Decathlon's own version of a super-shoe, as he runs an exceptional 5k road time. Speaking of Decathlon, a good week for the brand with Paul Seixas continuing his rise, this time with dominance in the Tour of the Basque Country, and hope for a challenger to Pogacar. A new research paper suggests doping prevalence among University students of 13.7%, but it uses novel statistical methods to get there, after only 3.4% of the athletes admit to PED use. We discuss that study, and what it means for anti-doping knowledge. Less covert (but only a little) about doping are the athletes of the upcoming Enhanced Games, recently valued at $1.2 billion, but now being transparently spoken about as a 'product launch' for longevity and performance enhancement drugs. The recently disclosed peptide stack of one competitor, world's strongest man Mitchell Hooper, is the basis for a chat about the grift those Games. Finally, our teen phenom watch list has two more names, 14-year old girls who broke 23s last week. Ross and Gareth wonder if the gap between adults and children is narrowing, or whether…